Chondroid chordoma of the skull base: immunohistochemical and ultrastructural study of two cases with special reference to microtubules within rough-surfaced endoplasmic reticulum.
Two cases of skull base chordoma (case 1, a 57-year-old woman; case 2, a 69-year-old woman) were investigated immunohistochemically and ultrastructurally. The tumors showed histopathological features typical of chondroid chordoma and contained both classical chordomatous and hyaline cartilaginous components. Tumor cells were immunoreactive for cytokeratin, vimentin, and S-100 protein, but negative for microtubule-associated protein 2 and class III beta-tubulin (tub-B3). Tumor cells of case 2 were immunoreactive for tau-protein and class II beta-tubulin (tub-B2), whereas those of case 1 were negative. Ultrastructurally, tumor cells in both cases showed the presence of abundant glycogen granules, well-developed intracellular organelles, and desmosome-like junctions. In case 2, several microtubules were closely packed and ran parallel or in random directions within the dilated cisterns of rough-surfaced endoplasmic reticulum (rough ER). "Microtubules within rough ER" has been described in several neoplasms, including classical and chondroid chordomas. Although previous reports documented the tub-B3 immunoreactivity in chordomas, our results suggested that, in our case 2, the predominant isoform of beta-tubulin in microtubules within rough ER was not tub-B3 but tub-B2.
Department of Pathology, Osaka Red Cross Hospital, Tennoji, Osaka 543-8555, Japan. masa-s@sings.jp
Masayuki
M
Shintaku
Kenichiro
K
Maeno
Hidetoshi
H
Okabe
D002817:Chordoma / Q000378:metabolism / Q000473:pathology / Q000648:ultrastructure*; D018870:Endoplasmic Reticulum, Rough / Q000378:metabolism / Q000473:pathology / Q000648:ultrastructure*; D005260:Female; D006801:Humans; D008870:Microtubules / Q000378:metabolism / Q000473:pathology / Q000648:ultrastructure*; D008875:Middle Aged; D019292:Skull Base Neoplasms / Q000378:metabolism / Q000473:pathology / Q000648:ultrastructure*
Cancer. 1973 Aug;32(2):410-20
4722921
Arch Pathol Lab Med. 1990 Sep;114(9):956-60
2390011
Arch Pathol Lab Med. 1993 Oct;117(10):1055-7
8215832
Ultrastruct Pathol. 1980 Jan-Mar;1(1):1-6
7233570
Pathol Int. 2005 Aug;55(8):453-63
15998372
Am J Surg Pathol. 1983 Oct;7(7):625-32
6638258
Ultrastruct Pathol. 1987;11(5-6):731-7
3686707
Kurume Med J. 2005;52(4):117-25
16639982
Ultrastruct Pathol. 1999 May-Jun;23(3):193-8
10445287
Ultrastruct Pathol. 1991 Jan-Feb;15(1):77-82
2011869
J Cell Biol. 1989 Aug;109(2):663-73
2503525
Annu Rev Cell Biol. 1988;4:687-716
3058169
Cancer Res. 1968 Oct;28(10):2115-25
5696940
Proc Natl Acad Sci U S A. 1986 Jun;83(12):4327-31
3459176
Am J Clin Pathol. 1999 Aug;112(2):189-93
10439798
Mod Pathol. 2003 May;16(5):453-9
12748252
Cell Motil Cytoskeleton. 2002 Jul;52(3):174-82
12112145
Am J Clin Pathol. 1994 Jan;101(1):36-41
7506477
J Pathol. 2006 Jun;209(2):157-65
16538613